These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 28913659)

  • 1. Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?
    John SA; Whitfield THF; Rendina HJ; Parsons JT; Grov C
    AIDS Behav; 2018 Apr; 22(4):1184-1189. PubMed ID: 28913659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S.
    Parsons JT; Rendina HJ; Whitfield TH; Grov C
    AIDS Behav; 2016 Jul; 20(7):1390-9. PubMed ID: 27000145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy.
    Meyers K; Rodriguez K; Moeller RW; Gratch I; Markowitz M; Halkitis PN
    PLoS One; 2014; 9(12):e114700. PubMed ID: 25502768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China.
    Meyers K; Wu Y; Qian H; Sandfort T; Huang X; Xu J; Zhang J; Xia W; Glidden D; Wu H; Shang H
    AIDS Behav; 2018 Apr; 22(4):1217-1227. PubMed ID: 28707025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to use and have sex with men taking HIV pre-exposure prophylaxis (PrEP): results of online surveys of Australian gay and bisexual men, 2011-2015.
    Holt M; Lea T; Schmidt HM; Kolstee J; Ellard J; Murphy D; Truong HH; de Wit J
    Sex Transm Infect; 2017 Sep; 93(6):438-444. PubMed ID: 28108701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To switch or not to switch: Intentions to switch to injectable PrEP among gay and bisexual men with at least twelve months oral PrEP experience.
    Meyers K; Wu Y; Brill A; Sandfort T; Golub SA
    PLoS One; 2018; 13(7):e0200296. PubMed ID: 30024903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation HIV Pre-Exposure Prophylaxis Preferences Among Men Who Have Sex with Men Taking Daily Oral Pre-Exposure Prophylaxis.
    Ellison J; van den Berg JJ; Montgomery MC; Tao J; Pashankar R; Mimiaga MJ; Chan PA
    AIDS Patient Care STDS; 2019 Nov; 33(11):482-491. PubMed ID: 31603712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among Young Adult Sexual Minority Men and Transgender Women.
    Weeden T; Garofalo R; Johnson AK; Schnall R; Cervantes M; Scherr T; Kuhns LM
    Acad Pediatr; 2024; 24(7):1110-1115. PubMed ID: 38631476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived Barriers to and Facilitators of Long-Acting Injectable HIV PrEP Use Among Black, Hispanic/Latino, and White Gay, Bisexual, and Other Men Who Have Sex With Men.
    Tran NK; Martinez O; Scheim AI; Goldstein ND; Welles SL
    AIDS Educ Prev; 2022 Oct; 34(5):365-378. PubMed ID: 36181495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intention and preference to use long-acting injectable PrEP among MSM in the Netherlands: a diffusion of innovation approach.
    Wang H; Zimmermann HML; van de Vijver D; Jonas KJ
    AIDS Care; 2024 Jul; 36(sup1):89-100. PubMed ID: 38713631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of Injectable and On-Demand Pre-Exposure Prophylaxis Among an Online Sample of Young Men Who Have Sex with Men in California.
    Beymer MR; Gildner JL; Holloway IW; Landovitz RJ
    LGBT Health; 2018; 5(6):341-349. PubMed ID: 30118399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of Awareness of and Willingness to Use Pre-exposure Prophylaxis (PrEP) in Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Geosocial-Networking Smartphone Applications in New York City.
    Goedel WC; Halkitis PN; Greene RE; Duncan DT
    AIDS Behav; 2016 Jul; 20(7):1435-42. PubMed ID: 26966013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.
    Cheng CY; Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Terris-Prestholt F
    BMC Public Health; 2019 Jul; 19(1):996. PubMed ID: 31340785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis.
    Levy ME; Patrick R; Gamble J; Rawls A; Opoku J; Magnus M; Kharfen M; Greenberg AE; Kuo I
    PLoS One; 2017; 12(8):e0183521. PubMed ID: 28827821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why I Quit Pre-Exposure Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP Discontinuation and Potential Re-initiation Among Gay and Bisexual Men.
    Whitfield THF; John SA; Rendina HJ; Grov C; Parsons JT
    AIDS Behav; 2018 Nov; 22(11):3566-3575. PubMed ID: 29404756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Awareness and Acceptability of pre-exposure prophylaxis (PrEP) among gay, bisexual and other men who have sex with men (GBMSM) in Kenya.
    Ogunbajo A; Kang A; Shangani S; Wade RM; Onyango DP; Odero WW; Harper GW
    AIDS Care; 2019 Oct; 31(10):1185-1192. PubMed ID: 31039628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Interest in Long-acting Injectable Pre-exposure Prophylaxis (LAI-PrEP) for HIV Prevention Among Men Who Have Sex With Men (MSM): Result From A Nationwide Survey in Malaysia.
    Paudel K; Gupta S; Gautam K; Wickersham JA; Khati A; Azwa I; Ha T; Shrestha R
    J Community Health; 2023 Jun; 48(3):513-521. PubMed ID: 36732459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs.
    Shrestha R; DiDomizio EE; Kim RS; Altice FL; Wickersham JA; Copenhaver MM
    J Subst Abuse Treat; 2020 Oct; 117():108058. PubMed ID: 32811633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men.
    Greene GJ; Swann G; Fought AJ; Carballo-Diéguez A; Hope TJ; Kiser PF; Mustanski B; D'Aquila RT
    AIDS Behav; 2017 May; 21(5):1336-1349. PubMed ID: 27770215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada.
    Newman PA; Guta A; Lacombe-Duncan A; Tepjan S
    J Int AIDS Soc; 2018 Nov; 21(11):e25211. PubMed ID: 30474351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.